Managing diabetic foot in times of COVID-19: time to put the best 'foot' forward
- PMID: 32904959
- PMCID: PMC7461755
- DOI: 10.1007/s13410-020-00866-9
Managing diabetic foot in times of COVID-19: time to put the best 'foot' forward
Abstract
Introduction: The COVID-19 pandemic has had an unparalleled impact on the socio-economic and healthcare structure of India. Due to our large populations of diabetic patients, who have an increased risk of worse outcomes with COVID-19 infection, it is of utmost public health importance to analyse the relationship between the two. The aim of our review was to analyse the possible relationship between COVID-19 infection and DFUs, which are a fairly common, yet serious complication in diabetic patients, as well as their management, under the given changing circumstances.
Methodology: An extensive review of related educational articles was analysed from various databases.
Results: The two main pathogenic mechanisms described in COVID-19 infection are a cytokine storm (causing ARDS) as well as an acquired coagulopathy, with widespread thrombosis. DFUs are associated with an underlying peripheral neuropathy, a chronic low-grade inflammatory state and peripheral arterial disease, which lead to chronic non-healing ulcers. Similarities seen in the pathogenic mechanisms of these two conditions make a bidirectional relationship highly plausible.
Conclusion: Due to the disruptions in the healthcare system brought on by the COVID-19 pandemic, changes in practice to a telehealth-driven approach, with emphasis on homecare and community clinics, need to be adopted, to ensure best possible care to patients with DFUs, in order to reduce their risk of DFU-related complications and need for hospitalization.
Keywords: COVID-19; Cytokine storm; Diabetic foot ulcers (DFU); Diabetic peripheral neuropathy (DPN); Ischemia.
© Research Society for Study of Diabetes in India 2020.
Conflict of interest statement
Conflicts of interestThe authors declare that they have no conflict of interest.
Figures
References
-
- 20200607-covid-19-sitrep-139.pdf [Internet]. [cited 2020 Jun 8]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... = 79dc6d08_2
-
- Gupta N, Agrawal S, Ish P, Gaind R, Arora B, Sen M, et al. Clinical and epidemiologic profile of the initial COVID 19 patients at a tertiary care centre in India. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli. Secondo Ateneo. 2020;90:193–196. - PubMed
-
- Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J [Internet]. 2020 May 14 [cited 2020 Jun 5];55(5). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/ - PMC - PubMed
-
- Solís P, Carreňo H. COVID-19 fatality and comorbidity risk factors among confirmed patients in Mexico [Internet]. Epidemiology; 2020 Apr [cited 2020 Jun 5]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.04.21.20074591 - DOI
-
- COVID-19 infection in people with diabetes – touchENDOCRINOLOGY [Internet]. [cited 2020 Jun 5]. Available from: https://www.touchendocrinology.com/insight/covid-19-infection-in-people-...
Publication types
LinkOut - more resources
Full Text Sources